NCT00754442View on ClinicalTrials.gov

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Secondary Hyperparathyroidism
Interventions
DRUG

Teriparatide

"Teriparatide will be given by continuous intravenous infusion at a rate of 12 pmol/kg/hr for 8 hours to both patients and controls"

Trial Locations (1)

21201

University of Maryland School of Medicine Division of Endocrinology, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00754442 - Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism | Biotech Hunter | Biotech Hunter